Search details
1.
Plasma tau, neurofilament light chain and amyloid-ß levels and risk of dementia; a population-based cohort study.
Brain
; 143(4): 1220-1232, 2020 04 01.
Article
in English
| MEDLINE | ID: mdl-32206776
2.
Immune age and biological age as determinants of vaccine responsiveness among elderly populations: the Human Immunomics Initiative research program.
Eur J Epidemiol
; 36(7): 753-762, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-34117979
3.
Naturally occurring antibodies isolated from PD patients inhibit synuclein seeding in vitro and recognize Lewy pathology.
Acta Neuropathol
; 137(5): 825-836, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30805666
4.
In Vitro Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in Mice.
J Virol
; 91(24)2017 12 15.
Article
in English
| MEDLINE | ID: mdl-29046448
5.
Immunological memory to hyperphosphorylated tau in asymptomatic individuals.
Acta Neuropathol
; 133(5): 767-783, 2017 05.
Article
in English
| MEDLINE | ID: mdl-28341999
6.
A common solution to group 2 influenza virus neutralization.
Proc Natl Acad Sci U S A
; 111(1): 445-50, 2014 Jan 07.
Article
in English
| MEDLINE | ID: mdl-24335589
7.
Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine.
Virol J
; 12: 210, 2015 Dec 08.
Article
in English
| MEDLINE | ID: mdl-26643820
8.
A pan-influenza monoclonal antibody neutralizes H5 strains and prophylactically protects through intranasal administration.
Sci Rep
; 14(1): 3818, 2024 02 15.
Article
in English
| MEDLINE | ID: mdl-38360813
9.
Biological age in healthy elderly predicts aging-related diseases including dementia.
Sci Rep
; 11(1): 15929, 2021 08 05.
Article
in English
| MEDLINE | ID: mdl-34354164
10.
SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques.
Nat Commun
; 12(1): 5877, 2021 10 07.
Article
in English
| MEDLINE | ID: mdl-34620860
11.
Pre- and postexposure use of human monoclonal antibody against H5N1 and H1N1 influenza virus in mice: viable alternative to oseltamivir.
J Infect Dis
; 200(12): 1870-3, 2009 Dec 15.
Article
in English
| MEDLINE | ID: mdl-19911992
12.
Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations.
J Vis Exp
; (150)2019 08 22.
Article
in English
| MEDLINE | ID: mdl-31498318
13.
Epitope mapping of diverse influenza Hemagglutinin drug candidates using HDX-MS.
Sci Rep
; 9(1): 4735, 2019 03 18.
Article
in English
| MEDLINE | ID: mdl-30894620
14.
A small-molecule fusion inhibitor of influenza virus is orally active in mice.
Science
; 363(6431)2019 03 08.
Article
in English
| MEDLINE | ID: mdl-30846569
15.
In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening.
J Vis Exp
; (141)2018 11 20.
Article
in English
| MEDLINE | ID: mdl-30531722
16.
Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia.
J Vis Exp
; (141)2018 11 09.
Article
in English
| MEDLINE | ID: mdl-30474638
17.
Structural Basis for Recognition of a Unique Epitope by a Human Anti-tau Antibody.
Structure
; 26(12): 1626-1634.e4, 2018 12 04.
Article
in English
| MEDLINE | ID: mdl-30318466
18.
Enhancement of therapeutic potential of a naturally occurring human antibody targeting a phosphorylated Ser422 containing epitope on pathological tau.
Acta Neuropathol Commun
; 6(1): 59, 2018 07 12.
Article
in English
| MEDLINE | ID: mdl-30001207
19.
A common antigenic motif recognized by naturally occurring human VH5-51/VL4-1 anti-tau antibodies with distinct functionalities.
Acta Neuropathol Commun
; 6(1): 43, 2018 05 31.
Article
in English
| MEDLINE | ID: mdl-29855358
20.
HA Antibody-Mediated FcγRIIIa Activity Is Both Dependent on FcR Engagement and Interactions between HA and Sialic Acids.
Front Immunol
; 7: 399, 2016.
Article
in English
| MEDLINE | ID: mdl-27746785